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Transposon Mutagenesis Identifies Uropathogenic Escherichia coli
Biofilm Factors
Maria Hadjifrangiskou,a* Alice P. Gu,b Jerome S. Pinkner,a,c Maria Kostakioti,a Ellisa W. Zhang,a Sarah E. Greene,a and
Scott J. Hultgrena,c
Department of Molecular Microbiology & Microbial Pathogenesis,a Center for Women’s Infectious Disease Research,c Washington University in Saint Louis School of
Medicine, St. Louis, Missouri, USA, and George Warren Brown School of Social Work, Washington University in Saint Louis, St. Louis, Missouri, USAb
Uropathogenic Escherichia coli (UPEC), which accounts for 85% of urinary tract infections (UTI), assembles biofilms in diverse
environments, including the host. Besides forming biofilms on biotic surfaces and catheters, UPEC has evolved an intracellular
pathogenic cascade that culminates in the formation of biofilm-like intracellular bacterial communities (IBCs) within bladder
epithelial cells. Rapid bacterial replication during IBC formation augments a build-up in bacterial numbers and persistence
within the host. Relatively little is known about factors mediating UPEC biofilm formation and how these overlap with IBC for-
mation. To address this gap, we screened a UPEC transposon mutant library in three in vitro biofilm conditions: Luria broth
(LB)-polyvinyl chloride (PVC), YESCA (yeast extract-Casamino Acids)-PVC, and YESCA-pellicle that are dependent on type 1
pili (LB) and curli (YESCA), respectively. Flagella are important in all three conditions. Mutants were identified that had biofilm
defects in all three conditions but had no significant effects on the expression of type 1 pili, curli, or flagella. Thus, this approach
uncovered a comprehensive inventory of novel effectors and regulators that are involved in UPEC biofilm formation under mul-
tiple conditions. A subset of these mutants was found to be dramatically attenuated and unable to form IBCs in a murine model
of UTI. Collectively, this study expands our insights into UPECmulticellular behavior that may provide insights into IBC forma-
tion and virulence.
The orchestrated sequence of events that leads to biofilm for-mation encompasses reversible and irreversible stages that re-
quire conserved and species-specific factors regulated by hierar-
chically organized genetic networks (44, 51, 53). These regulatory
systems respond to environmental cues to fine-tune the ordered
transition from planktonic growth to biofilm by directing gene
expression changes (41, 55, 56) and establishing developmental
checkpoints, which once passed, commit cells to a specific fate
(44). Biofilm-forming bacteria change their spatial and temporal
organization (44) and alter the expression of surface molecules
(41, 66), nutrient utilization and virulence factors (66), and resis-
tance mechanisms to environmental stresses. In addition, the
presence of environmental gradients within the biomass leads to
community “division of labor” with subpopulations of bacteria
exhibiting differential gene expression in response to local nutri-
ent and oxygen availability (19, 42). Combined, these attributes
confer a unique advantage to bacterial pathogens in biofilms and
makes their eradication particularly difficult, resulting oftentimes
in the establishment of chronic infections.
In the urinary tract, biofilm formation can lead to several
serious infections, not only in catheterized patients but also in
nonhospitalized individuals (21, 68). Eighty-five percent of com-
munity-acquired urinary tract infections (UTI) and 50% of de-
vice-associated UTI are caused by uropathogenic Escherichia coli
(UPEC) (24), which employ a complex pathogenic cascade in the
urinary tract, occupying extracellular and intracellular niches dur-
ing the course of infection (60). UTI studies inmousemodels have
identified numerous virulence factors, including adhesins, toxins,
iron acquisition systems, capsular structures, flagella, pathogenic-
ity islands, and factors important for biofilm formation (3, 26, 28,
69–71). UPEC strains have genes that encode amultitude of chap-
erone/usher pathway (CUP) pili (14, 16, 35, 45, 64). The biogen-
esis, structure, and function of CUP pili have been extensively
characterized (67). They typically contain adhesins at their tips
that recognize specific receptors with stereochemical specificity
(18, 30). For example, FimH, the type 1 pilus adhesin, binds man-
nosylated uroplakins, as well as N-linked oligosaccharides on 1
and 3 integrins that are expressed on the luminal surface of the
bladder epithelium (urothelium) inmice andhumans (20, 72, 73).
Binding to the luminal surface of human bladder tissue in situ has
been shown to be dependent on type 1 pili. Further, this binding
can lead to bacterial internalization (12, 20, 30, 43, 62, 63, 73).
Invading UPEC can be expelled from the host cell (10, 61), or they
can “escape” into the cell cytoplasm. Within this intracellular
niche, UPEC bacteria undergo a developmental process that cul-
minates in the formation of biofilm-like intracellular bacterial
communities (IBCs), comprising 104 to 105 tightly packed bacte-
ria, which appear to be enclosed in an extracellular matrix (5, 31,
33). Polysaccharides, such as the sialic acid capsule, are also pres-
ent throughout the IBC and function, in part, to protect the bac-
teria from neutrophil attack (3). Similar to extracellular biofilms,
IBCs are heterogeneous and composed of subpopulations with
different gene expression patterns (4). As IBCs enlarge, the eu-
karyotic cell volume becomes limiting, at which point UPEC cells
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alter theirmorphology, elongating and fluxing out of the host cell.
These filamentous UPEC bacteria are capable of dispersing and
reinitiating IBC formation in neighboring cells (31, 39).
One primary host defense that eliminates IBCs is exfoliation,
where urothelial cells undergo an apoptosis-like cell death, detach
from the underlying transitional epithelium, and are eliminated in
the urine (46, 47, 50). Exfoliated bladder epithelial cells containing
IBCs have been observed in urine collected from women with
recurrent UTI, but not in healthy controls or in cases of UTI
caused by Gram-positive pathogens (22, 57), demonstrating that
observations from experimental murine infection models reflect
human disease outcomes. However, exfoliation exposes underly-
ing cell layers of the urothelium. Subsequent UPEC invasion of
these underlying cells in mice results in the formation of addi-
tional intracellular structures termed quiescent intracellular res-
ervoirs (QIRs) (47, 50). Mouse models have been used to demon-
strate that bacteria in QIRs can contribute to recurrent infection
after antibiotic treatment has rendered the urine sterile (46–48).
Bacteria in the QIR are dormant, and studies have demonstrated
that 17 different antibiotics capable of killing the virulent cystitis
isolate UTI89 in vitro or in tissue culture, were unable to eliminate
UTI89 frommurine bladder tissue during bladder infection (11).
These findings indicate that IBC and QIR formation constitute
mechanisms that enable rapid bacterial expansion within a pro-
tected intracellular niche, shielded from host-mediated defenses
and therapeutic interventions, such as antibiotic treatment. Thus,
identifying factors that influence IBC formation either by impact-
ing type 1 pilus expression or by an independent mechanism will
advance our understanding of the regulatory systems that modu-
late UTI pathogenesis and will elucidate new targets for antiviru-
lence therapy.
Few factors mediating IBC development have been identified
thus far; studies have shown that type 1 pili are a critical IBC
determinant, as interruption of fim expression after UPEC adher-
ence and invasion of the bladder epithelium results in defects in
IBC formation and loss of virulence (70). In addition to type 1 pili,
sialic acid capsule has been implicated in IBC formation and
UPEC virulence (3). Recent studies have identified the QseC sen-
sor kinase as another IBC effector, as qseC deletion indirectly im-
pacts expression of type 1 pili and interferes with biofilm forma-
tion (25, 37). Besides type 1 pili, deletion of qseC also impacts curli
and flagella, two other critical UPEC biofilm determinants (37).
Flagella have been extensively implicated in biofilm formation by
E. coli (55), and several studies have shown that disruption of
motility also influences in vivoUPEC virulence (39, 59, 71). Curli
have also been shown to be important for E. coli biofilm formation
in specific environmental niches, and studies have linked curli
amyloid biogenesis to virulence (7, 15). Although the majority of
E. coli and Salmonella strains produce curli optimally at 30°C or
lower, many clinical UPEC and E. coli sepsis isolates express curli
at 37°C (9, 32). Furthermore, Cegelski and Pinkner et al. demon-
strated that low-molecular-weight inhibitors that disrupt curli
biogenesis are efficacious in reducing bacterial colonization and
IBC formation in a murine model of UTI (15), further linking
curli formation to UPEC pathogenesis.
The identification of additional factors that are involved in IBC
formation using large-scale in vivo screens has been difficult,
partly due to population bottlenecks that arise during in vivo in-
fection, which result in clonal IBC expansion (60). Given the bio-
film-like properties of IBCs, we hypothesized that identification of
biofilm effectors relevant in several in vitro conditions may pro-
vide insights into factors that contribute to fitness within the uri-
nary tract, which would thus surmount the need for large-scale in
vivo screening. Thus, we created a transposon mutant library in
the virulent cystitis isolate UTI89, which we screened in three
biofilm conditions: Luria broth (LB)-polyvinyl chloride (PVC),
YESCA (yeast extract-Casamino Acids)-PVC, and YESCA-pelli-
cle. These conditions were chosen, because they all depend on
factors that are implicated in UTI virulence. LB-PVC biofilms are
type 1 pili dependent, and YESCA-PVC and YESCA-pellicle bio-
films are curli dependent. Flagella are important for biofilm for-
mation in all 3 conditions. A total of 170 transposon (Tn)mutants
with reproducible niche-specific or broad biofilm differences
compared to wild-type (wt) UTI89 were identified. Of these, only
the 40 mutants that had altered biofilm phenotypes (increased or
reduced) under all conditions tested were considered for further
study. They were all analyzed for type 1 pilus, curli, and flagellum
expression in order to discernwhether a givenmutation identified
potentially new requisites for UPEC biofilm formation. A panel of
selected transposon mutants with disruptions in previously un-
characterized genes was found to be significantly attenuated in
their ability to cause infection and form IBCs, indicating that at
least some of these factors are also corequisites for IBC formation.
Further characterization of these effectors will provide valuable
insights into the mechanisms that underlie multicellular behavior
and virulence in UPEC and will elucidate new targets for the de-
velopment of antibiofilm agents.
MATERIALS AND METHODS
Bacterial strains and electrocompetent cells. UTI89 is a human cystitis
isolate that is highly virulent in a mouse model of UTI (47). UTI89 was
made electrocompetent after overnight growth in Luria broth (LB) me-
dium lacking salt (no-salt LB) at 37°C with shaking. One milliliter of the
overnight culture was used to inoculate 500 ml of prewarmed (37°C)
no-salt LB and incubated aerobically at 37°C, with shaking until it reached
an A600 of 0.6 to 0.75, at which point the culture was chilled on ice for 15
min. Bacterial cells were pelleted at 8,000 rpm for 10min, washed 2 times,
first in 75 ml of ice-cold 10% glycerol and then in 50 ml of ice-cold 10%
glycerol, and resuspended in 1 ml of ice-cold 10% glycerol. The resulting
electrocompetent cells had a transformation efficiency of 107 to 109
CFU/g of DNA. Nonpolar gene deletions were performed using the 
Red recombinase method (49).
Transposon mutagenesis. Transposon mutagenesis was performed
by electroporating 260 ng of the EZ-Tn5R6Kori/KAN-2Tnp Trans-
posome kit (Epicentre) in 100l of UTI89 electrocompetent cells accord-
ing to the manufacturer’s instructions (Epicentre), followed by a 60-min
recovery in SOCmedium (0.5% yeast extract, 2% tryptone, 10mMNaCl,
2.5mMKCl, 10mMMgCl2, 10mMMgSO4, and 20mMglucose) at 37°C.
The entire transposition reaction was then diluted 1:10,000 and plated in
100-l aliquots onLB-kanamycin plates to select for clones that contained
a successful transposition event.
Transposition mapping. Transposon mutations were mapped using
multiple-round PCR (6) and primer Inv-1 (ATGGCTCATAACACCCCT
TGTATTA) or Inv-2 (GAACTTTTGCTGAGTTGAAGGATCA). The re-
sulting ampliconswere purified (Qiagen) and sequenced using theKAN-2
FP-1 forward and KAN-2 RP-1 reverse primers (Epicentre).
Biofilm assays. Transposon mutants were grown logarithmically in 3
ml LB and normalized to an optical density at 600 nm (OD600) of 1. The
cultures were then diluted 200-fold in fresh LB or yeast extract-Casamino
Acids (YESCA)medium and used to seed biofilm plates. Biofilm assays in
LB and YESCA media at room temperature were performed in 96-well
PVC plates as previously described (54) and quantitatively measured 48 h
postseeding, using crystal violet (52). Biofilm production for eachmutant
Hadjifrangiskou et al.
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was normalized to the wtUTI89OD565 reading, whichwas set at 100% for
every run. Statistical analyses of three independent experiments were per-
formed on all assays, using paired Student’s t test (P  0.05, considered
significant). Pellicle formation assays in YESCAmedium were performed
in 48-well polystyrene plates at 30°C and qualitatively assessed at 48 h
postseeding.
Motility assays. Motility assays were performed as previously de-
scribed (71). Briefly, bacteria were incubated statically in LB for 18 h.
Swimming was assessed in 0.25% LB agar–0.001% 2,3,5-triphenyltetra-
zolium chloride. The plates were incubated at 37°C for 7 h. Motility was
evaluated by measuring the motility diameters. Experiment was repeated
5 times with triplicate plates for each strain.
HA assays. Bacteria were grown statically for 18 h and normalized to
an OD600 of 1 in 1 phosphate-buffered saline (PBS). Hemagglutination
(HA) assays were set up as described previously (29), using guinea pig red
blood cells (RBCs) normalized to an OD640 of 2. For assessment of S-
pilus-mediated adhesion, normalized RBCs were desialylated prior to the
HA analysis as follows: normalized RBCs (OD640 of 2.0) were centrifuged
at 3,000 rpm for 7 min, resuspended in 1 ml of 1 PBS, and incubated
with slow rocking at 37°C for 2 h in the presence of 10 l neuraminidase
(50 mU; EY Labs)–100 mM sodium acetate (pH 5.5) or 10 l of 100 mM
sodium acetate (pH 5.5) (untreated control). At the end of the incubation
period, the RBCs were centrifuged as described above to remove the en-
zyme and buffer, and the treated and untreated control RBCs were resus-
pended to an OD640 of 2.0 in 1 PBS.
Immunoblot analyses. For type 1 pili, cells were grown statically in LB
for 18 h at 37°C and normalized to an OD600 of 1. Prior to processing for
SDS-PAGE, samples were treated with 1 M HCl to dissociate pilin sub-
units, boiled for 5 min, and neutralized with 1 M NaOH prior to electro-
phoresis. Membranes were probed with antisera raised against type 1 pili
(54) at a 1:3,000 dilution.
Mouse infections. Female C3H/HeN mice (Harlan) that were 7 to 9
weeks old were transurethrally infected with 107 CFU of isolate UTI89
carrying the green fluorescent protein (GFP)-expressing plasmid pANT4
(17) by the method of Hannan et al. (26). pANT4 is stably harbored by
UPECduring the acute infection stages (31). Experiments were repeated 3
times, and statistical analyses were performed using the Mann-Whitney
test (two-tailed). A P of0.01 was considered significant. All procedures
involvingmice were performed in compliance with current federal guide-
lines and the institutional policies of the Washington University in Saint
Louis and ensured proper and humane treatment of animals.
Microscopy. Bladders excised from infected animals were treated for
confocal microscopy as previously described for IBC enumeration (71).
Briefly, the bladders were bisected, splayed, and fixed in 4% paraformal-
dehyde overnight at 4°C. The fixed bladders were washed and counter-
stained for 20min with the nuclear ToPro3 (Molecular Probes) stain, and
recombinant wheat germ agglutinin (r-WGA) to outline the facet cells
(1:700 dilution for each). Five bladders per mutant tested were scanned
per experiment. Images were obtained using a Zeiss LSM 510 Meta Laser
Scanning inverted confocal microscope (Thornwood). The average num-
bers of IBCs quantified in 3 independent experiments are reported. Sta-
tistical analyses were performed using a two-tailed Mann-Whitney test,
with a P of0.01 considered significant.
RESULTS AND DISCUSSION
An in vitro transposon screen identifiesUPECbiofilm effectors.
Wegenerated a transposon library in the prototypic cystitis isolate
UTI89, using the EZ-Tn5 R6Kgori/KAN-2Tnp “transpo-
some” (23). Of the 44,386 transposonmutants obtained using this
method, we were able to manually screen 6,144 (1 coverage) for
defects in three different biofilm conditions that are dependent on
three factors that are implicated in UPEC virulence to different
degrees: surface-associated biofilm on the walls of polyvinyl chlo-
ride (PVC) plates during static growth in room temperature LB
(type 1 pili dependent) or YESCA broth (curli dependent) and
floating pellicle biofilm formation during static growth in YESCA
broth at 30°C (curli dependent) (Fig. 1A). In addition to type 1 pili
and curli being critical determinants in the LB and YESCA biofilm
assays, respectively, flagellum formation is also known to be im-
portant in all three biofilm conditions. Biofilm formation on the
walls of PVC plates was measured at 48 h postinoculation using
the crystal violet colorimetric method of O’Toole et al. (52) and
normalized to values obtained for wild-type (wt) UTI89. The for-
mation of floating pellicle biofilms on the liquid-air interface of
YESCA broth at 30°C was scored visually, given a score of 0 to 4,
with 4 being wt and 0 being “no pellicle” (see also Table S2 in the
supplemental material).
Our initial screen identified a total of 234 biofilmmutants with
altered biofilm properties in one or more of the conditions tested.
Of the 234 mutants, 55 gave false-positive results and were dis-
carded and 9 could not bemaintained in culture, leaving a total of
170 transposon (Tn) mutants with consistently reproducible
niche-specific or broad biofilm differences compared to the wt
FIG 1 Transposon mutagenesis identifies mutants with broad and niche-specific biofilm defects in the virulent cystitis isolate UTI89. (A) Table depicting the
three screening conditions used to identify transposon (Tn)mutants with biofilm defects and the expected biofilm appearance of the parent strain, wt UTI89. LB
and YESCA-PVCbiofilm assays were set up in 96-well PVC plates in either LB or yeast extract-CasaminoAcids (YESCA)medium and incubated for 48 h at room
temperature. Pellicle biofilm assays were set up in 48-well polystyrene plates in YESCA medium and incubated at 30°C for 48 h. Identified Tn mutants with
biofilmdefects were rescreened under all conditions three times. EPS, extracellular polymeric substance. (B) Venn diagramdepicting the numbers of Tnmutants
obtained that had biofilm defects in one or more of the initial biofilm screening conditions.
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UTI89 isolate (Fig. 1B; see Table S1 in the supplemental material).
Of these, a total of 63mutants exhibited altered biofilm character-
istics in all three conditions tested. These mutants with broad
biofilm alterations were selected for further analysis after validat-
ing that the biofilm defects observed for each mutant were not
attributed to significant growth defects (data not shown). Using
nested PCR and a combination of transposon-specific primers, we
were able to map 54 of the 63 transposition events, identifying 40
chromosomal loci with nonpolar or polar gene disruptions (Table
S2). Functional analysis classified the 40 biofilm-related genes in 6
general categories, encompassing motility/attachment, LPS syn-
thesis/modification, metabolism and cell maintenance, as well as
regulatory or hypothetical functions (Fig. 2). Mutants with the
most significant quantifiable differences in biomass belonged to the
metabolism and hypothetical function group (Fig. 2C and F), while
mutantswithmoredramaticarchitecturaldifferencesbelongedto the
motility/attachment and lipopolysaccharide (LPS) synthesis modifi-
cation groups (Fig. 2A and B; see Fig. S1 in the supplemental mate-
rial). To validate our observations, we selected a panel of transposon
mutations from the LPS synthesis/modification,metabolismandhy-
pothetical function groups, which disrupted novel biofilm effectors
(Tn::C3813-purH, Tn::cvpA, Tn::plsX, Tn::carB, Tn::visC, and Tn::
rfe) and created clean, nonpolar deletions in isolateUTI89, whichwe
tested for their biofilm properties in LB-PVC and YESCA-PVC. In-
deed, all mutants exhibited similar phenotypes, as those exhibited by
the corresponding Tnmutants (Fig. S2). These analyses also demon-
strated that in the case of Tn::C3813-purH, the biofilm defect was
attributed to purHdisruption, as deletion ofUTI89_C3813 imparted
no biofilm defects, while the UTI89	purH strain exhibited a biofilm
phenotype identical to that of thebacteriawithTn::C3813-purH (Fig.
S2). In future studies, we will be generating clean gene deletions for
each factor identified in our screen to determine polar effects and
further characterize the contribution of each factor to UPEC biofilm
formation.
Assessmentof type1pilus, curli, andflagellumproduction in
mutants with generalized biofilm defects. Type 1 pili, curli, and
FIG 2 Functional classification of broad biofilm effectors. (A to F) Bar graphs showing the percent reduction or increase in biofilm formation on PVC plates by
the different Tn mutants compared to wt UTI89 during growth in LB or YESCA. Biofilm production for each mutant was normalized to the wt UTI89 OD565
reading, which was set at 100%. Data shown are averages of 3 different independent experiments. Statistical analyses were performed using paired Student’s t test
(*, P 0.05; **, P 0.005; ***, P 0.0003; blue asterisks denote significance for LB biofilm, red asterisks denote significance for YESCA biofilm relative to wt
UTI89). Photo panels accompanying each graph depict the appearance of pellicle biofilm produced in polystyrene plates by each Tnmutant after 48 h of growth
in YESCA medium at 30°C. Representative photos from 3 different experiments are shown.
Hadjifrangiskou et al.
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flagella are key niche-specific determinants of the three biofilm
conditions we used for our transposon library screening (Fig. 1A).
Althoughmutations in the fim operon encoding type 1 pili abolish
LB-PVC biofilms, they were not found to significantly affect
YESCA-PVC biofilms. Accordingly, of the 170 transposon mu-
tants with consistently reproducible niche-specific or broad bio-
film differences compared to wt UTI89, 12 were in the fim operon
and disrupted type 1 pili, impacting biofilm formation in LB-PVC
and pellicle (2/3 conditions tested [see Table S1 in the supplemen-
tal material]). Mutant strains with mutations in fim while defec-
tive in LB biofilms still produce YESCA biofilms. Similarly, we
identified 2 Tn mutants with disruptions in the csg operons en-
coding curli, and these abolished YESCA, but not LB PVC, bio-
films (see Table S1 in the supplementalmaterial). Thus,mutations
in the fim and csg operons were not analyzed further in this study,
as we carried through only the 40 mutants that had defects in all 3
biofilm conditions tested. However, since type 1 pili, curli, and
flagella have known contributions to the various three biofilm
conditions tested, we investigated the impact of each of these 43
mutations on the expression of each of these organelles in order to
assess the novelty of themutation versus a secondary effect on one
of these known factors.
(i) Swimming motility. We assessed swimming motility on
soft agar plates (0.03%) for each mutant, compared to the wt
UTI89 isolate, over a 7-h incubation period. In this assay, the 9
nonmotile mutants disrupted for flagellar assembly or regulation
(22.5% of the total [see Fig. S1 in the supplemental material])
served as controls (Fig. 3A). Of the remaining 31 Tn mutants
tested, 2 exhibited increased motility (Tn::rfaGQ and Tn::ylbF-
arcC [Fig. 3]), while 13 exhibited reducedmotility. These reduced
motility mutants were the Tn::rfe (LPS [Fig. 3B)]; Tn::pyrE, Tn::
mdh, Tn::trkH, Tn::pyrF-sui, and Tn::nuoLK (metabolism [Fig.
3C]); Tn::tar, Tn::qseC, and Tn::spoT (regulators [Fig. 3D]); Tn::
greB and Tn::pgm (cell maintenance [Fig. 3E]); and Tn::visC and
Tn::yfiLR (hypothetical/other [Fig. 3F]) mutants. We have previ-
ously reported that deletion of qseC results in downregulation of
motility by reducing the expression of flhDC. Similar analysis on
the clean visC deletion mutant demonstrated no significant
changes in flhDC or fliC expression (data not shown), suggesting
that the effect on motility in this mutant occurs at the posttran-
scriptional level. We are currently studying the cause of the loss of
motility in the nonmotile biofilm mutants. Taken together, the
swimming motility assays indicate that approximately 50% of
mutants with biofilm defects did not impact motility, suggesting
that the corresponding factors influence biofilm formation by af-
fecting an alternate pathway.
(ii) Type 1 pili.Next, we measured type 1 piliation by the abil-
ity of each mutant to mediate mannose-sensitive hemagglutina-
tion (MS-HA) (29). Expression of type 1 pili can be evaluated by
the ability of UPEC to agglutinate guinea pig red blood cells
(RBCs) via recognition of mannosylated receptors by the FimH
adhesin. Type 1 piliated UTI89 typically produces an HA titer
(log2) of 8 to 9 (29). The addition of mannose competitively in-
hibits type 1 pilus-mediated adhesion. Under the conditions
tested, wt UTI89 typically expresses primarily type 1 pili. The ad-
dition of soluble D-mannose (2%) inhibits the HA reaction by
competitively binding FimH and blocking bacterial binding to the
mannosylated erythrocytes, thereby reducing the HA titer to 0 or
1 (29). The expression of other pilus systems can mediate hemag-
glutination that ismannose-resistant HA (MR-HA) (37).We thus
used HAs in the presence and absence of D-mannose to assess the
effects of each Tnmutation on expression of type 1 (MS-HA) and
other adhesins (MR-HA). We detected significant reduction in
type 1 pilus-mediated HA in only 8/40 mutants (20%), with the
Tn::mdh, Tn::qseC, Tn::visC, and Tn::ylbF-arcC mutants exhibit-
ing the most significant defects (HA  7 [Fig. 4]). Interestingly,
theTn::qseC, Tn::mdh, andTn::visCmutantswere also defective in
motility, a surprising observation given that motility and type 1
pilus expression are typically inversely related (40). We are cur-
rently investigating this phenomenon. In order to validate the HA
results, we performed Western blot analyses on a subset of Tn
mutants with different HA titers (Tn::visC, Tn::rfe, Tn::yfiLR, Tn::
2312, Tn::C1545, and Tn::ylbF-arcC), probing for the major pilus
subunit, FimA. Indeed, FimA protein levels in eachmutant corre-
sponded to the recorded HA (see Fig. S3 in the supplemental ma-
terial), with the Tn::visC and Tn::ylbF-arcC mutants producing
miniscule amounts of FimA, while the Tn::rfe, Tn::yfiLR, and Tn::
C1545 mutants produced wt levels of FimA protein (Fig. S3).
Numerous regulatory factors control expression of type 1 pili,
including three major recombinases that alter the orientation of
the invertible fimpromoter element (1, 2, 13, 34). It is possible that
disruption of visC and ylbF-arcC impact expression and/or func-
tion of regulatory elements, thus affecting the phase variation of
the fim promoter, or fim gene transcription. Future studies are
aimed at addressing these possibilities.
Interestingly, our HA analyses revealed that 18 mutants (45%
of allmutants) had induced slight tomoderateMR-HA (Fig. 4; see
Table S1 in the supplemental material), indicative of induction of
other adhesive organelles besides type 1 pili. We have previously
shown that in the absence of the qseC sensor kinase, the observed
MR-HA is attributed to upregulation of S-pili (25, 37) To examine
whether S-pili were responsible for the inducedMR-HA in the Tn
mutants with MR-HA, we assessed HA, using RBCs treated with
Arthrobacter ureafaciens neuraminidase to remove sialic acid, the
putative receptor of S-pili (36). Desialylation of RBCs should
abolish binding via S-pili, thus reducing the MR-HA to 0 or 1,
unless other CUPs or adhesins are responsible for the observed
MR-HA. Our assay revealed that in 16 out of the 18 mutants with
MR-HA, desialylation of RBCs abolished MR-HA (see Fig. S4 in
the supplemental material), indicating that disruption of the cor-
responding factors somehow induces the upregulation of S-pili.
The 2 Tn mutants (Tn::rrsH and Tn::rfe mutants) that continued
to exhibit MR-HA in the absence of sialic acid may have other
adhesins that are upregulated or unmasked upon disruption of
these factors, similar to what has previously been described (8, 27,
58, 65).
(iii) Curli.The ability of the different Tnmutants to form curli
was evaluated on YESCA agar plates, using Congo red (CR) up-
take as a proxy to wt curli production. We detected no significant
curli defects in themajority ofmutants (30/40, or 75% [see Fig. S5
in the supplemental material]). These findings suggest that the
majority of biofilm defects observed in the Tn mutants during
growth in YESCA are not attributed to defective curli expression.
Notably, of the 10 mutants with strikingly altered CR uptake, 6
belong to metabolic/cell maintenance processes (Tn::pgm, Tn::
greB, Tn::rrsH, Tn::ygeX, Tn::mdh, and Tn::carB), while 3 (Tn::
waaW, Tn::waaL, and Tn::cvpA) belong to the LPS modification
pathway or have hypothetical or uncharacterized functions. In
addition to a defect in curli production, altered CR uptake may
also point to a defect in cellulose or poly--1,6-N-acetyl-D-gluco-
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samine (PGA) production. Further analysis of these mutants will
elucidate whether cellulose and PGA are perturbed.
Clustering analysis of mutants with generalized biofilm de-
fects.Our in vitro assays probing for type 1 pili, curli, and flagella
indicated that the majority of Tn mutants that had defects in all
three biofilm conditions tested did not have significant defects in
production of these organelles. To further investigate these re-
sults, we used a clustering approach to assess whether there were
FIG 3 Motility properties of broad biofilm effectors. (A to F) Bar graphs depicting average motility diameters (in millimeters) of the different Tn mutants
compared to the wt UTI89 after 7 h growth in soft LB agar (0.25%). Average motility diameters were calculated using data from 3 independent experiments.
Statistical analyses were performed using unpaired, two-tailed Student’s t test, with P 0.05 considered significant. *, P 0.05; **, P 0.005; ***, P 0.0003.
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FIG 4 HAproperties of broad biofilm effectors. (A to F) Bar graphs showing theHA properties of each Tnmutant compared to those of the wt UTI89 in the presence
and absence of 4% D-mannose. Expression of type 1 pili can be evaluated by the ability of UPEC to agglutinate guinea pig red blood cells (RBCs) via recognition of
mannosylated receptors by the FimH adhesin. The addition ofmannose competitively inhibits type 1 pilus-mediated adhesion. Under the conditions tested, wt UTI89
typically expresses primarily type 1pili; thus, the additionofmannosedrops agglutination to anHAof 0 to1.The small degreeof agglutination remaining in thewt strain
is attributable to some expression of S-pili. However, upon the addition of mannose, the HA of several Tn mutants did not drop to the typical 0 to 1, suggestive of
additional pili systems that may be upregulated in these systems. The graphs depict average HA titers from 2 independent experiments. Statistical analyses were
performed using unpaired, two-tailed Student’s t test, with P 0.05 considered significant. *, P 0.05; **, P 0.005; ***, P 0.0003.
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correlations between the pattern of biofilm phenotypes observed,
based on quantitative biofilm defects under the three conditions
tested, and the pattern of MS-HA, MR-HA, curli and flagellar
phenotypes exhibited by each of the mutants. We first grouped all
mutants based on biofilm severity and sorted them according to
the effect of each mutation on the expression of type 1 pili (mea-
sured by MS-HA), curli (measured by CR uptake), or flagella
(measured by motility). Architectural mutants with biofilm accu-
mulation between 85% and 115% of the wild type were clustered
as wt. Using this method, we discovered that most of the muta-
tions that affected curli- and type 1-dependent biofilm formation
did not always affect expression of those corresponding organ-
elles. Thus, in these cases, these unique mutants may have led to
the discovery of new factors that are important under these bio-
film conditions. Also, loss or gain of motility did not strongly
correlate with loss or gain of biofilm formation in the different
mutants (Fig. 5). Specifically, we found that some nonmotile mu-
tants had increased biofilm formation, while others exhibited
strong biofilm defects (Fig. 5). These results have elucidated new
genes and pathways possibly involved in initial adherence and
intercellular aggregation, independent of type 1 pili, curli, and
flagella, but which are important in type 1- and curli-dependent
biofilms. Increased LB-PVC biofilm (Fig. 5, bottom quadrant)
correlated with higher or wt levels of MS-HA (Fig. 5), but loss/
reduction of LB-PVC biofilm did not have a strong correlation
with reducedMS-HA (Fig. 5). Similarly, loss/reduction of CR up-
take did not always correlate with reduced YESCA-PVC or pellicle
biofilm (Fig. 5).
Taken together, these findings demonstrate that type 1 pili and
curli are necessary but not sufficient for LB-PVC and YESCA-
PVC/pellicle formation, respectively, and point toward other fac-
tors that are critical for proper biofilm formation under these
conditions. In addition, the fact that these mutants express wt
levels of type 1 pili and flagella, both of which have been exten-
sively associated with initial adherence (38, 52, 55), supports the
idea that the disrupted factors are corequisites for biofilm forma-
tion ormay be involved at a stage in biofilm formation that is likely
after initial adherence. Further studies investigating the stage at
FIG 5 Clustering of broad biofilm mutant in vitro phenotypes. Mutants were clustered on the basis of phenotype severity; mutants were sorted by LB-PVC
phenotype severity, followed by sorting based on the severity on YESCA-PVC, pellicle, motility, and CR uptake phenotypes. The colors indicate phenotype gain
(green) or loss (red) compared to wt UTI89. In the biofilm value columns, the gray background denotes mutants with architectural biofilm defects that
quantitatively produced 85% to 115% biomass compared to wt UTI89.
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which these factors become important will provide more insights
into themechanisms that underlie multicellularity under the con-
ditions tested.
Type 1 pilus-independent in vivo fitness defects in UTI. The
role of biofilm determinants other than type 1 pili in IBC forma-
tion is largely unknown. Thus, we tested the in vivo fitness of a
panel of Tnmutants (Tn::visC, Tn::ylbF-arcC, Tn::C1545-46, Tn::
yfiLR, and Tn::rfemutants) that exhibited a variety of biofilm de-
fects and type 1 piliation phenotypes from wt to nonpiliated on
the basis of the results ofMS-HA andWestern blot analysis (Fig. 5;
see Fig. S2 in the supplemental material). Female C3H/HeNmice
were then transurethrally inoculated with 107 CFU GFP-express-
ing strains of UTI89 or Tn::visC, Tn::yfiLR, Tn::C_1545-46, Tn::
ylbF-arcC, and Tn::rfemutant strains, The Tn::wtmutant, a trans-
posonmutant with no biofilm defects, was included to control for
any transposon-mediated effects. Bladder CFU and IBC numbers
weremonitored at 16 hpostinfection (hpi),marking the endof the
first IBC cycle at which time bacteria are found in late-stage IBCs
or in the process of filamentation and dispersal (31). IBCs were
enumerated by confocal microscopy as described previously (37).
As expected, the Tn::wt strain colonized the bladder and formed
IBCs at levels comparable to those of the wt UTI89 (Fig. 6A to C).
All Tn mutants tested had at least 10-fold-lower bladder titers
compared to wt UTI89 (Fig. 6A) and formed significantly fewer
IBCs (Fig. 6B and C), with the exception of the Tn::C1545-46
mutant. The Tn::rfe mutant appeared to be mostly extracellular
(Fig. 6C), with very few IBCs observed at 16 h postinfection. In
order to validate these observations, we used two clean deletion
FIG 6 Hypothetical protein biofilmmutants are defective in vivo. (A and B) Graphs showing bladder titers (A) and IBC numbers (B) recovered 16 hpi with each
Tn mutant. IBCs were enumerated by confocal microscopy as described in Materials and Methods. A P  0.01 was considered significant by two-tailed
Mann-Whitney test. (C) Confocal images (63) depicting the bladder epithelial surface from mice infected with wt UTI89 or the corresponding Tn mutants.
Bladder tissue is stainedwith wheat germ agglutinin (red), nuclei are stainedwith ToPro-3 iodide (blue), andUPEC are expressing GFP (green). A representative
image is shown for each mutant. The experiment was repeated 3 times, and 5 bladders per mutant tested were imaged per experiment. (D) Graph and confocal
imaging depicting IBC numbers enumerated for the corresponding UTI89	visC and UTI89	rfe nonpolar deletion mutants, both at 6 h and 16 h postinfection.
The experiment was repeated twice. A P of0.01 was considered significant by the two-tailed Mann-Whitney test. *, P 0.05; **, P 0.005; ***, P 0.0003.
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mutants that had different effects on type 1 pilus expression:
UTI89	visC (reduced type 1 pili) and UTI89	rfe (no effects on
type 1 pili expression). Introduction of these clean deletion mu-
tants in mice andmonitoring of CFU and IBC formation revealed
that both mutants were significantly impaired in their ability to
form IBCs (Fig. 6D), consistent with the results obtained using the
transposon mutants. These observations are striking in that we
have now discovered a panel of UPEC factors that affect IBC for-
mation independent of type 1 pilus expression and whenmutated
attenuate virulence. Further analysis of such type 1 piliated mu-
tants, such as UTI89	rfe, will uncover their specific roles in UPEC
biofilm formation in vitro and in vivo.We are currently investigat-
ing these and other nonpolar clean deletion mutants further.
Concluding remarks.Collectively, our studies have elucidated
an inventory of UPEC factors that impact biofilm formation ei-
ther by interferingwith known, critical biofilmdeterminants or by
yet uncharacterized mechanisms. In vivo analysis using a murine
model of acute cystitis revealed that a randomly selected panel of
biofilm mutants with variable defects in type 1 pilus expression
was equally attenuated in their ability to cause infection and form
IBCs. These factors not only constitute potential drug target can-
didates for antibiofilm therapeutics but can be extensively utilized
as molecular scalpels for extending the characterization of biofilm
development. Further analysis of the pathways to which all these
novel factors belong will elucidate molecular mechanisms in-
volved in UPEC biofilm formation in vitro and in vivo and will
advance our efforts in preventing or disassemblingUPECbiofilms
within the host.
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